Boaz Weinstein’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-756,253
Closed -$52.7K 599
2023
Q3
$52.7K Hold
756,253
﹤0.01% 375
2023
Q2
$105K Hold
756,253
﹤0.01% 364
2023
Q1
$64.3K Hold
756,253
﹤0.01% 521
2022
Q4
$34.8K Hold
756,253
﹤0.01% 684
2022
Q3
$109K Hold
756,253
﹤0.01% 760
2022
Q2
$83K Hold
756,253
﹤0.01% 848
2022
Q1
$170K Buy
+756,253
New +$196K ﹤0.01% 756

Boaz Weinstein's BIOSW Position: Q4 2023 in Review

Boaz Weinstein sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 756,253 shares — an estimated $52.7K sold.

Boaz Weinstein first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $170K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Boaz Weinstein reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Boaz Weinstein sold 756,253 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $52.7K.
  • Boaz Weinstein first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Boaz Weinstein's BioPlus Acquisition Corp. Warrants position peaked at $170K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Saba Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.